Veien til forskning

New technology makes it easier to work with big data sets. Here three examples of how to use data and AI, from Bergen, Oslo and Trondheim.

The impact of AI
v/Valeria Vitelli, Biostatistikk og Integreat, UiO
AI has already revolutionized drug discovery, and it is impacting clinical trials with tremendous gains. In the long run, possibilities for enhancing human health are enormous.

Bioinformatics with ELIXIR@UiB
v/Sushma Nagaraja Grellscheid, Head of ELIXIR Norway
This talk will highlight how ELIXIR Norway enables secure, ethical, and interoperable sharing of health and genomic data, linking national efforts with European initiatives. It will cover the Norwegian FEGA node for controlled access to sensitive data, as well as contributions to 1+MG and GDI, supporting a coordinated European framework for sensitive data access and analysis. Together, these efforts position ELIXIR Norway as a key actor in advancing FAIR, secure, and scalable health data sharing for research and personalised medicine.

Genetisk variasjon og helsedata på befolkningsnivå
v/Oddgeir Lingaas Holmen, Forsker, HUNT Cloud, NTNU & NORTRE
Jobber for NORTRE og har forsket på sammenhenger mellom genetisk variasjon og sykdom på befolkningsnivå. Han er særlig opptatt av å øke verdien av store helsedatasett.

This session will be both in english and Norwegian.

Moderator: Espen Rosenborg, EHiN